In addition, our findings confirmed (i) the high discriminative performance of tau imaging to distinguish DLB from AD (Kantarci et al., 2016; Ossenkoppele et al., 2018) and (ii) support a role of tau to underlie cognitive dysfunction in DLB (Gomperts et al., 2016). This evidence concerns the gene MAPT and Alzheimer disease.